Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phenotypic diversity in chondromyxoid fibroma reveals differentiation pattern of tumor mimicking fetal cartilage canals development: an immunohistochemical study.
Zustin J, Akpalo H, Gambarotti M, Priemel M, Rueger JM, Luebke AM, Reske D, Lange C, Pueschel K, Lohmann C, Rüther W, Amling M, Alberghini M. Zustin J, et al. Among authors: luebke am. Am J Pathol. 2010 Sep;177(3):1072-8. doi: 10.2353/ajpath.2010.100171. Epub 2010 Jul 29. Am J Pathol. 2010. PMID: 20671262 Free PMC article.
[Intramuscular myxoma of the lower leg].
Luebke AM, Gocke C, Priemel M, Grob TJ, Zustin J. Luebke AM, et al. Pathologe. 2013 Jul;34(4):360-3. doi: 10.1007/s00292-012-1718-1. Pathologe. 2013. PMID: 23179208 German.
Diagnostic and Therapeutic Pathways of Intramuscular Myxoma.
Reiter A, Trumm K, Ballhause TM, Weiss S, Frosch KH, Korthaus A, Bechler U, Duprée A, Luebke A, Bannas P, Schlickewei CW, Priemel MH. Reiter A, et al. Diagnostics (Basel). 2022 Jun 28;12(7):1573. doi: 10.3390/diagnostics12071573. Diagnostics (Basel). 2022. PMID: 35885479 Free PMC article.
Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer.
Hinsch A, Brolund M, Hube-Magg C, Kluth M, Simon R, Möller-Koop C, Sauter G, Steurer S, Luebke A, Angerer A, Wittmer C, Neubauer E, Göbel C, Büscheck F, Minner S, Wilczak W, Schlomm T, Jacobsen F, Clauditz TS, Krech T, Tsourlakis MC, Schroeder C. Hinsch A, et al. World J Urol. 2018 Jun;36(6):877-882. doi: 10.1007/s00345-018-2225-7. Epub 2018 Feb 9. World J Urol. 2018. PMID: 29427004
Expression of the immune checkpoint receptor TIGIT in seminoma.
Hinsch A, Blessin NC, Simon R, Kluth M, Fischer K, Hube-Magg C, Li W, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin NF, Höflmayer D, Lennartz M, Sauter G, Izbicki JR, Minner S, Büscheck F, Uhlig R, Dum D, Krech T, Luebke AM, Wittmer C, Jacobsen F, Burandt E, Steurer S, Wilczak W. Hinsch A, et al. Among authors: luebke am. Oncol Lett. 2019 Aug;18(2):1497-1502. doi: 10.3892/ol.2019.10428. Epub 2019 May 31. Oncol Lett. 2019. PMID: 31423216 Free PMC article.
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer.
Kind S, Büscheck F, Höflmayer D, Hube-Magg C, Kluth M, Tsourlakis MC, Steurer S, Clauditz TS, Luebke AM, Burandt E, Wilczak W, Hinsch A, Dum D, Weidemann S, Fraune C, Beyer B, Steuber T, Huland H, Graefen M, Fisch M, Simon R, Sauter G, Schlomm T, Minner S, Eichenauer T. Kind S, et al. Among authors: luebke am. World J Urol. 2020 Sep;38(9):2185-2196. doi: 10.1007/s00345-019-03017-w. Epub 2019 Nov 19. World J Urol. 2020. PMID: 31745645
115 results